Michael Motschmann

Michael Motschmann has made 29 investments in companies such as: Siltectra, Hemovent, AFFiRiS, KEWAZO, Corimmun, GWA Hygiene, immatics biotechnologies, BioNTech, IDENT Technology, Protagen, Sovicell GmbH, Biocrates Life Sciences, NavVis, Second Closet, advanceCOR, Isarna Therapeutics, Ganymed Pharmaceuticals, Liva Healthcare, NFON, KONUX, AMSilk, German Bionic, LXP Group GmbH, SuppreMol, IQM, PDC Biotech, Efficient Energy, Innatera Nanosystems, Cynora.

Location of Michael Motschmann is Munich, Germany.

The free version of Angel Match provides limited data for Michael Motschmann. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

Michael Motschmann is a General Partner and he his investment types are: Venture Capital.
Michael Motschmann focuses investing in industries such as: Biotechnology, Commercial, Customer Service, Transportation, Warehousing, Apps, Fitness, Health Care, mHealth, Wellness, Artificial Intelligence, Industrial Automation, Open Source, Robotics, Wearables, CleanTech, Energy, Energy Efficiency, Environmental Engineering, GreenTech, Manufacturing, Analytics, Construction, Health Diagnostics, Computer, Hardware, Product Design, Quantum Computing, Chemical, Lighting.

A short brief about investor:


Past investments

  • Siltectra
  • Hemovent
  • AFFiRiS
  • Corimmun
  • GWA Hygiene
  • immatics biotechnologies
  • BioNTech
  • IDENT Technology
  • Protagen
  • Sovicell GmbH
  • Biocrates Life Sciences
  • NavVis
  • Second Closet
  • advanceCOR
  • Isarna Therapeutics
  • Ganymed Pharmaceuticals
  • Liva Healthcare
  • NFON
  • AMSilk
  • German Bionic
  • LXP Group GmbH
  • SuppreMol
  • IQM
  • PDC Biotech
  • Efficient Energy
  • Innatera Nanosystems
  • Cynora

Social media:

Available after registration.